E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/29/2006 in the Prospect News Biotech Daily.

Non-Invasive Monitoring Systems receives patent for AT-101 for arthritis

By Elaine Rigoli

Tampa, Fla., March 29 - Non-Invasive Monitoring Systems, Inc. received notice of allowance for a U.S. patent on its flagship product, the AT-101.

This patent, which includes 73 claims, has three major topics: the device itself, medical applications that are current and planned, and means to modify the AT-101 in the future such that it performs as a non-invasive ventilator as a substitute or supplement for current mechanical ventilators, according to a news release.

The European patent office also recently allowed the claims for the first U.S. Patent 6,155,976 granted in December 2000, reciprocating movement platform for shifting subject to and fro in headwards-footwards direction.

This patent forms the basis of the AT-101 technology, the release said.

This will allow broad market protection for marketing the AT-101 therapeutic vibrator as a drug-free means to provide acute relief of minor aches and pains associated with osteoarthritis of the hip as well as developing and marketing a less expensive, home version of this device, officials said.

Non-Invasive Monitoring, located in North Bay Village, Fla., specializes in products that use a natural approach to assist subjects without the use of drugs or any invasive procedures.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.